Results of an updated meta-analysis reveal that COX-2 inhibitors still appear to increase BP to a greater degree than nonselective (ns)-NSAIDs Clinical study 19 January 2013 Pages: 3 - 3
Late stent thromboses cost DES cost effectiveness in the US Clinical study 19 January 2013 Pages: 3 - 3
Gemfibrozil/methotrexate/piperacillin/tazobactam interaction Case report 19 January 2013 Pages: 15 - 15